Masahiko Matsuo
President and Representative Director
pharmaceutical
Meiji Holdings Co., Ltd.
Japan
Biography
"The Meiji Group business activities are driven by our mission to widen the world of “Tastiness and Enjoyment†and meet all expectations regarding “Health and Reassurance.†We provide a wide variety of products, including dairy, confectionery, nutritionals and pharmaceuticals that are invaluable to the daily lives of all generations of consumers, from infants to the elderly. In FY2016, our consolidated operating income increased substantially, representing the fifth consecutive year of increased earnings. In the food segment, we focused our resources on core products and implemented structural reforms, resulting in a significant increase in income. In the pharmaceutical segment, although we saw favorable performance overseas, the impact of NHI pricing revisions and market slowdown were greater than expected in Japan, leaving us issues need to be addressed. It is the final year of our FY2015-FY2017 Group Medium-Term Business Plan, STEP UP 17. Our core theme is to strengthen priority businesses and our management platform and accelerate sustainable growth and greater improvement in profitability."
Research Interest
biomedical devices